Media Center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
Lindsay Bosslet, MPH

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

Recent Press Coverage

  1. Malawi is likely to sign the African Medicines Agency (AMA) Treaty soon. PATH’s Johnpaul Omollo talks about how the AMA will help harmonize regulatory systems and improve access to quality medical products in Africa.
    Published: May 2023
  2. Malawi’s first-ever national typhoid vaccination campaign begins this month. PATH’s Esau Mkisi explains how PATH and the Ministry of Health are working together to make this campaign a success.
    Published: April 2023
  3. PATH Director of HPV Vaccine Programs, Cathy Ndiaye, writes for the Gates Foundation about the importance of vaccinating to prevent cervical cancer in low- and middle-income countries.
    Published: April 2023
  4. Since 2018, the Global Health Design Collaborative at Makerere University has been working to develop a safe waste management solution for women using the DMPA-SC self-injectable contraceptive, and PATH is set to take over operations and implementation.
    Published: March 2023

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

915 Items
915 Items
915 Items
    Date
    From
    To
  1. Resolution urges action to sustain gains and drive progress toward reliable and sustained oxygen access for all
    Published: May 2023
    Press Release
  2. Results from a Phase 3 clinical study of a pentavalent meningococcal meningitis vaccine candidate designed for use in the African meningitis belt demonstrate it to be safe, well tolerated, and capable of producing strong immune responses to all five serogroups.
    Published: May 2023
    Announcement
  3. Published: May 2023
    Announcement
  4. Antibodies specific to SARS-CoV-2 WA01 (Wuhan) and Omicron, Delta variants produced to help speed the development and testing of vaccines globally.
    Published: May 2023
    Press Release
  5. PATH, as part of the Global Self-Care Federation, joins a global call to reorient health systems to primary health care and self-care as a resilient foundation for universal health coverage.
    Published: May 2023
    Announcement